Raphaël Heinzer (University Hospital of Lausanne, Lausanne, Switzerland) talks to us about the prevalence of obstructive sleep apnoea (OSA) in Europe, the importance of current clinical pathways for its diagnosis and treatment, and provides expert advice on identifying signs and symptoms, as well as what to do for patients at high risk.
1. You recently co-authored a paper looking at the prevalence of obstructive sleep apnoea (OSA) in Europe, could you please tell us about the study and your findings? (0:11)
2. How will current clinical pathways handle the identification, diagnosis and treatment of the estimated 175 million Europeans with OSA? (0:48)
3. There have not been many OSA prevalence studies conducted in the past, why do you think that is? (1:08)
4. What is the impact of untreated OSA? (1:35)
5. For the medical community not familiar with OSA, what are the signs and symptoms that they should look for in assessing if their patient may have OSA? If they feel that their patient is at high risk for OSA, what should they do? (2:07)
Speaker disclosure: Raphaël Heinzer is an advisory board member for NightBalance and Dream devices and receives speaker fees from Philips.
Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018, supported by ResMed.
Share this Video
Related Videos In Sleep Related Breathing Disorders
Jan Hedner, ERS 2021: Sulthiame for Moderate to Severe Obstructive Sleep Apnoea
We were delighted to talk with Professor Jan Hedner (The University of Gothenburg, Gothenburg, Sweden) around the rationale, and safety and efficacy findings of using sulthiame in moderate to severe obstructive sleep apnoea. The abstract ‘Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial’ (Presentation ID 4383) […]
Terri Weaver, CHEST 2020 – Solriamfetol in Obstructive Sleep Apnea
Following her related presentation at CHEST 2020, Terri Weaver (University of Illinois Chicago, Chicago, IL, USA) took the time to speak with us about the long term effects of solriamfetol on excessive daytime sleepiness and functional outcomes in participants with obstructive sleep apnea. Questions 1. What is known about the long and short term efficacy […]
Margaret Pisani, CHEST 2020 – Sleep and Circadian Rhythm
We caught up with our Editorial Board member Margaret Pisani (Yale University School of Medicine, New Haven, CT, USA) to talk about her presentation at CHEST 2020 Virtual around sleep and circadian rhythm. Questions 1. What are the alterations to sleep and circadian rhythm that are seen in the ICU? Do these affect outcomes? (0:07) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!